Vassileva, S.; Murrell, D. F. .; Culton, D. A. .; Ujiie, H.; Hertl, M.; Goebeler, M.; Sinha, A. A.; Schmidt, E.; Stoykov, I.; Verheesen, P.; Borradori, L.; Werth, V. P.; Joly, P. Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+). J of Skin 2024, 8, s345.